Autoimmune Diseases and HIV

Autoimmune diseases arise when inherited autoimmunity progress to pathogenic autoimmunity. Genetic factors as well as environmental causes dictate this development. The global market size of Autoimmune Disease Therapeutics was $109,833 million in 2017 and is expected to reach $153,320 million by the end of 2025, with a CAGR of 4.2% 2018-2025.

HIV is a category of diseases caused by human immunodeficiency virus infection. HIV weakens the immune system and impedes the ability of the body to combat disease as they destroy T cells, macrophages and dendritic cells. There is no treatment for HIV at the moment, but there are many clinical studies devoted to a cure. Developing an HIV vaccine would save millions of lives. Share your research findings on Autoimmunity and HIV to the world; this can be possible by our Immunology Congress.

    Related Conference of Autoimmune Diseases and HIV

    March 18-19, 2021

    3rd World Conference on Vaccine and Immunology

    Dubai, UAE
    April 05-05, 2021

    Tumor & Cancer Immunology and Pediatric-Oncology

    Toronto, Canada
    May 03-04, 2021

    International Online Conference on Immunology

    New York, USA
    June 23-24, 2021

    34th World Congress on Vaccines and Immunization

    Osaka, Australia
    October 12-13, 2021

    International Conference on Vaccine and Vaccine research

    Manila, Philippines
    October 14-15, 2021

    13th Annual Conference on Cinical Immunology

    Cape Town, Australia
    October 14-15, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa

    Autoimmune Diseases and HIV Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in